In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers

التفاصيل البيبلوغرافية
العنوان: In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers
المؤلفون: Karin V. Niessen, Thomas Seeger, Georg Höfner, Horst Thiermann, Franz Worek, Klaus T. Wanner, Thomas Wein, Sebastian Rappenglück
المصدر: Toxicology Letters. 293:190-197
بيانات النشر: Elsevier BV, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Male, 0301 basic medicine, Obidoxime, Pyridines, Antidotes, Diaphragm, Soman, Pyridinium Compounds, Muscarinic Antagonists, Receptors, Nicotinic, Pharmacology, Toxicology, Structure-Activity Relationship, 03 medical and health sciences, chemistry.chemical_compound, Organophosphate Poisoning, 0302 clinical medicine, medicine, Animals, Chemical Warfare Agents, Nicotinic Agonists, Rats, Wistar, Nerve agent, Chemistry, Stereoisomerism, General Medicine, Bridged Bicyclo Compounds, Heterocyclic, Receptors, Muscarinic, Acetylcholinesterase, Rats, Nicotinic acetylcholine receptor, 030104 developmental biology, Nicotinic agonist, Epibatidine, Cholinergic, Cholinesterase Inhibitors, 030217 neurology & neurosurgery, Acetylcholine, Muscle Contraction, medicine.drug
الوصف: The primary toxic mechanism of organophosphorus compounds, i.e. nerve agents or pesticides, is based on the irreversible inhibition of acetylcholinesterase. In consequence of the impaired hydrolysis, the neurotransmitter acetylcholine accumulates in cholinergic synapses and disturbs functional activity of nicotinic and muscarinic acetylcholine receptors by overstimulation and subsequent desensitization. The resulting cholinergic syndrome will become acute life-threatening, if not treated adequately. The current standard treatment, consisting of administration of a competitive mAChR antagonist (e.g. atropine) and an oxime (e.g. obidoxime, pralidoxime), is not sufficient in the case of soman or tabun intoxications. Consequently, alternative therapeutic options are necessary. An innovative approach comprises the use of compounds selectively targeting nAChRs, especially positive allosteric modulators, which increase the population of the conducting receptor state. MB327 (1,1′-(propane-1,3-diyl)bis(4-tert-butylpyridinium) di(iodide)) is able to restore soman-blocked muscle-force in preparations of various species including human and was recently identified as “resensitizer”. In contrast to the well-studied MB327, the pharmacological efficacy of the 2- and 3-tert-butylpyridinium propane regioisomers is unknown. As a first step, MB327 and its 3-regioisomer (PTM0001) and 2-regioisomer (PTM0002) were pharmacologically characterized using [3H]epibatidine binding assays, functional studies by solid supported membranes based electrophysiology, and in vitro muscle-force investigations of soman-poisoned rat hemidiaphragm preparations by indirect field stimulation technique. The results obtained from targets of different complexity (receptor, muscle tissue) showed that the pharmacological profiles of the 2- and 3-regioisomers were relatively similar to those of MB327. Furthermore, high concentrations showed inhibitory effects, which might critically influence the application as an antidote. Thus, more effective drugs have to be developed. Nevertheless, the combination of the methods presented is an effective tool for clarifying structure-activity relationships.
تدمد: 0378-4274
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7671cbcf2f717eb13a2528cb07f378Test
https://doi.org/10.1016/j.toxlet.2017.10.009Test
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....ae7671cbcf2f717eb13a2528cb07f378
قاعدة البيانات: OpenAIRE